A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia
about
The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trialA randomized, double-blind, placebo-controlled trial of eszopiclone for the treatment of insomnia in patients with chronic low back pain.Insomnia (primary) in older people.A randomized controlled trial of mindfulness meditation for chronic insomnia.Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youthEffects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind studyPharmacological Treatment of Insomnia.Impact of brief cognitive behavioral treatment for insomnia on health care utilization and costs.Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients.Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies.Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.Management of insomnia in elderly patients using eszopiclone.Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.Reducing hypnotic use in insomnia management among Australian veterans: results from repeated national interventions
P2860
Q30301208-6E09B439-ED2F-43F3-8EEE-E17930B7534DQ33587570-60A924F0-4F65-4033-981D-0585053FF221Q34059258-A8E108CE-0253-4D2C-95DC-C428DEAADCC3Q34125927-9D2ECDAF-1745-4BFD-A8A7-6AC4B7E3BA61Q35761878-68261046-DC55-40C0-9846-3FDED29142A6Q36198401-2AA87180-A9A6-4347-A793-60B404210026Q36251904-061AA194-A0B3-45B5-BA1A-07BC8723BE40Q37505919-CB8CFB90-93CD-4167-BE75-4012FAF2BA5FQ38372503-C6985037-6CA8-4FF8-AD65-FCCF27FD9101Q38864277-38E8FDD8-37EA-455E-967D-4EAD216C9014Q39044821-77C24B93-5EFF-4953-BE55-1858A608449BQ39960467-20A54EBC-B99B-4BE2-9A39-43D842259C34Q55478187-795E1703-3C18-498C-A1B7-81516963FCFEQ57304985-A2882108-7EFD-4546-B5FE-9CD65672EB2E
P2860
A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A 12-week, randomized, double- ...... primary and comorbid insomnia
@ast
A 12-week, randomized, double- ...... primary and comorbid insomnia
@en
type
label
A 12-week, randomized, double- ...... primary and comorbid insomnia
@ast
A 12-week, randomized, double- ...... primary and comorbid insomnia
@en
prefLabel
A 12-week, randomized, double- ...... primary and comorbid insomnia
@ast
A 12-week, randomized, double- ...... primary and comorbid insomnia
@en
P2093
P2860
P1433
P1476
A 12-week, randomized, double- ...... primary and comorbid insomnia
@en
P2093
Amy Wilson
Andrew D Krystal
Kendyl Schaefer
Raymond Claus
Robert Rubens
Thomas Roth
W Vaughn McCall
P2860
P304
P577
2010-02-01T00:00:00Z